<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>识林 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-27T09:14:15+08:00</updated>
  <subtitle>服务于制药行业企业、机构及人员的知识与管理平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【质量对话】质量，疫情间被遗忘的角落？</title>
    <updated>2020-12-27T06:37:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/8wPcNYOma2D4x-d0PX9b0g</id>
    <link href="https://mp.weixin.qq.com/s/8wPcNYOma2D4x-d0PX9b0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗加速生产下 CMO 面临的挑战</title>
    <updated>2020-12-26T06:33:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/9NqE8zxKfPZXLBHwPdFXWw</id>
    <link href="https://mp.weixin.qq.com/s/9NqE8zxKfPZXLBHwPdFXWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 对仿制螺内酯新适应症的特殊支持、审评及专家会意见</title>
    <updated>2020-12-25T06:03:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/FXQy02Qm0Ujn_Bjtke51LQ</id>
    <link href="https://mp.weixin.qq.com/s/FXQy02Qm0Ujn_Bjtke51LQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>行业组织要求 FDA 提供更多可互换生物制品指南</title>
    <updated>2020-12-25T06:03:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/5q1FH8z8pAM6xgkFzvHO8g</id>
    <link href="https://mp.weixin.qq.com/s/5q1FH8z8pAM6xgkFzvHO8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>WHO 关于利福喷丁和利福平中亚硝胺问题的更新</title>
    <updated>2020-12-24T06:33:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/1keTFIL6wQLazs1d5bpRVw</id>
    <link href="https://mp.weixin.qq.com/s/1keTFIL6wQLazs1d5bpRVw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>英国和印度或于下周批准阿斯利康新冠疫苗</title>
    <updated>2020-12-24T06:33:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/ZLnVs5vzrsTC7l2aBTK8dA</id>
    <link href="https://mp.weixin.qq.com/s/ZLnVs5vzrsTC7l2aBTK8dA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧洲药典发布亚硝胺通则，更新 CEP 认证的当前状况</title>
    <updated>2020-12-23T06:35:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/f4hN7rN-pPbiZunLMKjgQw</id>
    <link href="https://mp.weixin.qq.com/s/f4hN7rN-pPbiZunLMKjgQw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 发布疫情期间审评时限指南，试图降低申请人期望减少抱怨</title>
    <updated>2020-12-23T06:35:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/EpEMhS91al0OIh1FG8v1CA</id>
    <link href="https://mp.weixin.qq.com/s/EpEMhS91al0OIh1FG8v1CA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧盟附条件批准辉瑞-BioNTech 新冠疫苗</title>
    <updated>2020-12-22T06:36:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/2d4DHxnaELbhy_CLtr0Xhw</id>
    <link href="https://mp.weixin.qq.com/s/2d4DHxnaELbhy_CLtr0Xhw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>印度新冠疫苗试验不良反应引发质疑，辉瑞疫苗需要在印度本地试验</title>
    <updated>2020-12-22T06:36:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/oB5EUKb2brwIgHZVH7BokQ</id>
    <link href="https://mp.weixin.qq.com/s/oB5EUKb2brwIgHZVH7BokQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一周回顾：经口吸入仿制药生物等效性指导，AAV基因治疗产品CMC开发案例解析，FDA授权第二个新冠疫苗，欧盟转基因细胞产品指南</title>
    <updated>2020-12-21T06:40:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/-cJr0RJhYNT6oz201fjtnQ</id>
    <link href="https://mp.weixin.qq.com/s/-cJr0RJhYNT6oz201fjtnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧盟基因和细胞治疗药物开发指南，含CAR-T细胞特殊临床考虑</title>
    <updated>2020-12-21T06:40:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/G_a1AmpUnnVNVJHBFJgblw</id>
    <link href="https://mp.weixin.qq.com/s/G_a1AmpUnnVNVJHBFJgblw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【周末杂谈】法律、律师与 FDA</title>
    <updated>2020-12-20T06:33:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/36VD_eeS-y1ru1IjeDdBTw</id>
    <link href="https://mp.weixin.qq.com/s/36VD_eeS-y1ru1IjeDdBTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗领跑者已撞线，后来者面临更多试验执行困难</title>
    <updated>2020-12-19T06:43:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/JBx3N56fKbehdz2b5ZNzIQ</id>
    <link href="https://mp.weixin.qq.com/s/JBx3N56fKbehdz2b5ZNzIQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【快讯】Moderna 新冠疫苗专家会意见，20-0 支持紧急使用授权</title>
    <updated>2020-12-18T06:30:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/86b_ADmMv76DVCyuig80Rw</id>
    <link href="https://mp.weixin.qq.com/s/86b_ADmMv76DVCyuig80Rw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA专家会幻灯片：Moderna新冠疫苗作用机理、有效性、安全性和临床观点</title>
    <updated>2020-12-18T06:30:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/zGARsqWYhX7w9FaDwTkZvw</id>
    <link href="https://mp.weixin.qq.com/s/zGARsqWYhX7w9FaDwTkZvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>